Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer
Goetz M, Price G, Gainford M, Andre V, Shekarriz S, Stoffregen C, Toi M, Huober J, Park I, Tokunaga E, Martín M, Johnston S. Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer. Oncologist 2020; 25:e1346-e1354.
24.06.2020
Health-Related Quality of Life in MONARCH 3: Abemaciclib plus an Aromatase Inhibitor as Initial Therapy in HR+, HER2- Advanced Breast Cancer
24.06.2020
Oncologist 2020; 25:e1346-e1354
Goetz Matthew P, Price Gregory L, Gainford M Corona, Andre Valerie, Shekarriz Sarah, Stoffregen Clemens, Toi Masakazu, Huober Jens, Park In Hae, Tokunaga Eriko, Martín Miguel, Johnston Stephen
Weiter
